MondegarAI
FourWorld Capital Management LLC

Q3 2025 · 13F-HR

FourWorld Capital Management LLCholdings as filed

Filed 2025-11-14 · accession 0001770525-25-000010

$63.3M
Reported value
24
Positions
2025-09-30
Period end
View analyzed profile →PRO

The Brief · FourWorld Capital Management LLC · Q3 2025

AI · grounded in 13F

FourWorld Capital Management LLC established a new position in SPY valued at $17.3M. The fund also initiated new stakes in EVLV for $7.1M and SRG for $4.7M. Other new additions include ABUS at $4.6M, BMY at $4.5M, and AIRS at $4.3M. The fund ended the period with 23 positions and total AUM of $63.3M.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
78462F103SPYSPDR S&P 500 ETF TR$17.3M27.3%26,000PUTSOLE
30049H102EVLVEVOLV TECHNOLOGIES HLDNGS IN$7.1M11.3%944,902CommonSOLE
81752R100SRGSERITAGE GROWTH PPTYS$4.7M7.47%1,113,243CommonSOLE
03879J100ABUSARBUTUS BIOPHARMA CORP$4.6M7.32%1,020,910CommonSOLE
110122108BMYBRISTOL-MYERS SQUIBB CO$4.5M7.12%100,000CommonSOLE
464287655IWMISHARES TR$3.6M5.73%15,000PUTSOLE
009496100AIRSAIRSCULPT TECHNOLOGIES INC$3.1M4.95%391,156CommonSOLE
30068X103XGNEXAGEN INC$2.5M3.94%227,000CommonSOLE
87652V109TASKTASKUS INC$1.8M2.82%100,000CommonSOLE
83422N105SLDPSOLID POWER INC$1.7M2.61%477,129CommonSOLE
64131A105STIMNEURONETICS INC$1.6M2.45%568,000CommonSOLE
98923K103ZKNZEEKR INTELLIGENT TECHNOLOGY$1.5M2.40%49,789CommonSOLE
68236X100TOITHE ONCOLOGY INSTITUTE INC$1.2M1.97%358,000CommonSOLE
126638105CVRXCVRX INC$1.2M1.85%145,000CommonSOLE
29271Q103ESOAENERGY SVCS ACQUISITION CORP$1.2M1.84%112,357CommonSOLE
009496100AIRSAIRSCULPT TECHNOLOGIES INC$1.1M1.77%140,000CALLSOLE
237266101DARDARLING INGREDIENTS INC$1.0M1.66%34,000CommonSOLE
48581R205KSPIKASPI KZ JSC$816,8001.29%10,000CommonSOLE
98262P200WWWW INTL INC$797,5441.26%29,150CommonSOLE
09225M101BSMBLACK STONE MINERALS L P$653,2421.03%49,714CommonSOLE
B38564108CMBTCMB.TECH NV$503,3700.79%53,607CommonSOLE
60742B102MOBBWMOBILICOM LTD$476,2620.75%51,211CommonSOLE
127537207CDZICADIZ INC$151,2430.24%32,043CommonSOLE
88165K119TVGNWTEVOGEN BIO HLDGS INC$79,7500.13%1,450,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.